patent/EA-201591687-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201591687-A1

Outgoing Links

Predicate	Object
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate	2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EA-201591687-A1
titleOfInvention	INDUCTION THERAPY RITUXIMAB WITH SUBSEQUENT TREATMENT USING ACCETATE GLATIRAMER
abstract	The invention relates to a method of treating a subject affected by a form of multiple sclerosis or demonstrating a clinically isolated syndrome, including periodically administering a certain amount of anti-CD20 antibody to a specified subject at least twice, followed by periodic administration of a certain amount of Glatiramer acetate, where the indicated amounts are effective for treating a subject .
priorityDate	2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65370 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081884 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448746680 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454270819

Total number of triples: 33.